Sickle cell trait was associated with DNA-marking and age-estimate differences
Among African American participants, sickle cell trait was associated with differences in blood DNA markings and some biological-age estimates. The age findings depended on the estimating method and do not establish shortened lifespan.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Sickle cell trait was associated with differences in DNA methylation, meaning chemical markings on DNA, and with higher biological-age estimates from some methods. The pattern varied across these estimating tools. This study identifies associations in blood measurements; it does not establish that the trait causes faster clinical aging, particular illnesses or a shorter life.
The abstract reports that age associations differed across estimating methods but gives no effect sizes or confidence intervals. It presents these findings as groundwork for future research on aging and health outcomes.
What the DNA analysis found
Researchers searched across DNA-marking sites for associations with sickle cell trait. The strongest signals appeared near the beta-globin gene cluster, while other associated sites involved genes related to oxidation and the regulation of chemical reactions.
What an age clock measures
Epigenetic clocks are tools that estimate biological age using DNA markings. Newer clocks incorporating clinical features or laboratory markers showed accelerated age estimates, but results were not consistent across clocks and were not direct measures of lifespan.
The original publication
Methylation profile of individuals with sickle cell trait.
Vasconcelos AG, Johnson M, Cai Y et al.
Epigenetics · 2025
- PubMed ID
- 40758858
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.